Status:
COMPLETED
Prospective Evaluation of FibroScan in Patients Treated With Methotrexate
Lead Sponsor:
Association HGE CHU Bordeaux Sud
Conditions:
Liver Fibrosis
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this study is to evaluate liver fibrosis using FibroScan and biochemical markers in patients treated with methotrexate.
Detailed Description
Methotrexate (MTX) is an effective treatment for induction of remission and maintenance in patients with Crohn's disease, rheumatoid arthritis, or psoriasis which may induce liver fibrosis with high c...
Eligibility Criteria
Inclusion
- Male or female subjects, ≥18 years of age.
- Patient treated with Methotrexate.
- Written informed consent
Exclusion
- Patients refusing to participate to the study and to provide written informed consent
- Pregnant women
Key Trial Info
Start Date :
January 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2019
Estimated Enrollment :
1871 Patients enrolled
Trial Details
Trial ID
NCT00673101
Start Date
January 1 2006
End Date
July 1 2019
Last Update
July 5 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hopital du Haut Leveque
Pessac, France, 33600